SF002-96-1, a new drimane sesquiterpene lactone from an Aspergillus species, inhibits survivin expression

Silke Felix, Louis P. Sandjo, Till Opatz and Gerhard Erkel
Beilstein J. Org. Chem. 2013, 9, 2866–2876. https://doi.org/10.3762/bjoc.9.323

Supporting Information

Supporting Information File 1: 1D and 2D NMR spectra of compound SF002-96-1.
Format: PDF Size: 432.7 KB Download

Cite the Following Article

SF002-96-1, a new drimane sesquiterpene lactone from an Aspergillus species, inhibits survivin expression
Silke Felix, Louis P. Sandjo, Till Opatz and Gerhard Erkel
Beilstein J. Org. Chem. 2013, 9, 2866–2876. https://doi.org/10.3762/bjoc.9.323

How to Cite

Felix, S.; Sandjo, L. P.; Opatz, T.; Erkel, G. Beilstein J. Org. Chem. 2013, 9, 2866–2876. doi:10.3762/bjoc.9.323

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Cui, Q.; Huang, C.; Liu, J.-Y.; Zhang, J.-T. Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective. Journal of medicinal chemistry 2023, 66, 16515–16545. doi:10.1021/acs.jmedchem.3c01130
  • Yuan, J.; Liu, Z.; Dong, Y.; Gao, F.; Xia, X.; Wang, P.; Luo, Y.; Zhang, Z.; Yan, D.; Zhang, W. Pioneering 4,11-Dioxo-4,11-dihydro-1H-anthra[2,3-d]imidazol-3-ium Compounds as Promising Survivin Inhibitors by Targeting ILF3/NF110 for Cancer Therapy. Journal of medicinal chemistry 2023, 66, 16843–16868. doi:10.1021/acs.jmedchem.3c01551
  • Li, M.; Zhao, Q.; Liao, J.; Wang, X.; Liu, L.; Zhang, X.; Liu, L.; Liu, H.; Zhang, S. Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells. Journal of Cancer 2023, 14, 2027–2038. doi:10.7150/jca.85011
  • Gill, H.; Sykes, E. M. E.; Kumar, A.; Sorensen, J. L. Isolation of Bioactive Metabolites from Soil Derived Fungus-Aspergillus fumigatus. Microorganisms 2023, 11, 590. doi:10.3390/microorganisms11030590
  • Albadari, N.; Li, W. Survivin Small Molecules Inhibitors: Recent Advances and Challenges. Molecules (Basel, Switzerland) 2023, 28, 1376. doi:10.3390/molecules28031376
  • DU, W.; Yang, Q.; Xu, H.; Dong, L. Drimane-type sesquiterpenoids from fungi. Chinese journal of natural medicines 2022, 20, 737–748. doi:10.1016/s1875-5364(22)60190-0
  • Huang, Y.; Valiante, V. Chemical Diversity and Biosynthesis of Drimane-Type Sesquiterpenes in the Fungal Kingdom. Chembiochem : a European journal of chemical biology 2022, 23, e202200173. doi:10.1002/cbic.202200173
  • Beckmann, L.; Tretbar, U. S.; Kitte, R.; Tretbar, M. Anticancer Activity of Natural and Semi-Synthetic Drimane and Coloratane Sesquiterpenoids. Molecules (Basel, Switzerland) 2022, 27, 2501. doi:10.3390/molecules27082501
  • Zhao, W.-Y.; Yi, J.; Chang, Y.-B.; Sun, C.-P.; Ma, X. Recent studies on terpenoids in Aspergillus fungi: Chemical diversity, biosynthesis, and bioactivity. Phytochemistry 2021, 193, 113011. doi:10.1016/j.phytochem.2021.113011
  • Peery, R. C. Ph.D. Thesis, April 8, 2020.
  • Lacey, H. J.; Gilchrist, C. L.; Crombie, A.; Kalaitzis, J. A.; Vuong, D.; Rutledge, P. J.; Turner, P.; Pitt, J. I.; Lacey, E.; Chooi, Y.-H.; Piggott, A. M. Nanangenines: drimane sesquiterpenoids as the dominant metabolite cohort of a novel Australian fungus, Aspergillus nanangensis. Beilstein journal of organic chemistry 2019, 15, 2631–2643. doi:10.3762/bjoc.15.256
  • Song, Z.; Liu, Y.; Gao, J.; Hu, J.; He, H.; Dai, S.; Wang, L.; Dai, H.; Zhang, L.; Song, F. Antitubercular metabolites from the marine-derived fungus strain Aspergillus fumigatus MF029. Natural product research 2019, 35, 2647–2654. doi:10.1080/14786419.2019.1660331
  • Li, F.; Aljahdali, I.; Ling, X. Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?. Journal of experimental & clinical cancer research : CR 2019, 38, 368. doi:10.1186/s13046-019-1362-1
  • Kim, S.; Ko, D.; Lee, Y.; Jang, S.; Lee, Y.; Lee, I. Y.; Kim, S. Anti-cancer activity of the novel 2-hydroxydiarylamide derivatives IMD-0354 and KRT1853 through suppression of cancer cell invasion, proliferation, and survival mediated by TMPRSS4. Scientific reports 2019, 9, 10003. doi:10.1038/s41598-019-46447-7
  • Shojaei, F.; Yazdani-Nafchi, F.; Banitalebi-Dehkordi, M.; Chehelgerdi, M.; Khorramian-Ghahfarokhi, M. Trace of survivin in cancer. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2019, 28, 365–372. doi:10.1097/cej.0000000000000453
  • Martínez-García, D.; Manero-Rupérez, N.; Quesada, R.; Korrodi-Gregório, L.; Soto-Cerrato, V. Therapeutic strategies involving survivin inhibition in cancer. Medicinal research reviews 2018, 39, 887–909. doi:10.1002/med.21547
  • Peery, R. C.; Liu, J.-Y.; Zhang, J. T. Targeting survivin for therapeutic discovery: past, present, and future promises. Drug discovery today 2017, 22, 1466–1477. doi:10.1016/j.drudis.2017.05.009
  • Pandey, M. K.; Prasad, S.; Tyagi, A. K.; Deb, L.; Huang, J.; Karelia, D. N.; Amin, S.; Aggarwal, B. B. Targeting Cell Survival Proteins for Cancer Cell Death. Pharmaceuticals (Basel, Switzerland) 2016, 9, 11. doi:10.3390/ph9010011
  • Shao, F.-Y.; Wang, S.; Li, H.-Y.; Chen, W.-B.; Wang, G.-C.; Ma, D.-L.; Wong, N.-S.; Xiao, H.; Liu, Q.-Y.; Zhou, G.-X.; Li, Y.-L.; Li, M.-M.; Yifei, W.; Liu, Z. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells. Oncotarget 2016, 7, 6790–6808. doi:10.18632/oncotarget.6828
  • Nadumane, V. K.; Venkatachalam, P.; Gajaraj, B. Aspergillus Applications in Cancer Research. New and Future Developments in Microbial Biotechnology and Bioengineering; Elsevier, 2016; pp 243–255. doi:10.1016/b978-0-444-63505-1.00020-8
Other Beilstein-Institut Open Science Activities